Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospitalWarfarin initiation nomograms for venous thromboembolismProthrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patientsVitamin K for improved anticoagulation control in patients receiving warfarinWarfarin initiation nomograms for venous thromboembolismProthrombin complex concentrate for perioperative reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients requiring acute surgical interventionVitamin K for improved anticoagulation control in patients receiving warfarinWarfarin initiation nomograms for venous thromboembolismSpontaneous lingual and sublingual haematoma: a rare complication of warfarin useThe European guideline on management of major bleeding and coagulopathy following trauma: fourth editionGuidelines on oral anticoagulation with warfarin - fourth editionProthrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trialBest strategies for patient education about anticoagulation with warfarin: a systematic reviewProthrombin Complex Concentrates for Bleeding in the Perioperative Setting.Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleedingA French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal.Thromboembolism.Management of bleeding following major trauma: an updated European guideline.Management of patients receiving oral anticoagulants using computer dosing software--does everyone agree? Data from a UK NEQAS (blood coagulation) exercise.Prothrombin complex concentrates: an update.The health care setting rather than medical speciality impacts on physicians adherence to guideline-conform anticoagulation in outpatients with non-valvular atrial fibrillation: a cross sectional survey.Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study.Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage.Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage.UK Transfusion Laboratory Collaborative: minimum standards for staff qualifications, training, competency and the use of information technology in hospital transfusion laboratories 2014An audit of the role of vitamin K in the reversal of International Normalised Ratio (INR) in patients undergoing surgery for hip fracture.Management of warfarin anticoagulation in patients with fractured neck of femur.Perioperatively acquired disorders of coagulation.Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.Reversal of warfarin-induced hemorrhage in the emergency department.A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care.Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.Predictors of warfarin-induced bleeding in a South Indian cardiology unitThe Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial.Best practice in primary care pathology: review 8.Efficacy of Prothrombin Complex Concentrate Treatment in Patients with Liver Coagulopathy Who Underwent Various Invasive Hepatobiliary and Gastrointestinal ProceduresHaematology and neurology.
P2860
Q21092902-3D3AB99B-D044-4850-8B3A-95BFBB9F1470Q21195016-708813D7-034E-47E8-A1A7-DB85E65EF4EFQ24186324-1C027E4F-6AD7-4DAA-B761-03F4EE9DC6DBQ24186523-01E08EF3-7C66-4C86-911A-AC57C27F1553Q24194649-C4544901-0543-40B6-BE09-4AB49F5C2788Q24201274-E8066BC2-875F-432B-9E7F-C2D3F1CD87F6Q24202561-415D9B95-27D5-4316-A9F1-A09D2F057306Q24202915-CE241AD2-3C85-4062-9571-25E5E9604640Q24240381-5D6B9BA0-4B06-429A-A28C-D697B96004B8Q26829379-4BAB1545-2157-4931-B33B-72AA43942B1CQ27339343-D4F44212-CAE2-404B-96F9-8B23B41BBC9BQ28240666-9E34A92D-4F33-428D-91C0-728AA9489E21Q28265484-E868E606-49F9-4B8B-B2E6-4DB6B202D8D2Q33319899-52E9C345-2E04-4110-8291-540A89A90CD4Q33430766-7EC11A50-E299-4917-BC43-5C581FD9AC98Q33612839-BD7676E0-BC59-47E3-A6BF-BE299569A687Q33754796-CBBE1971-9F67-4C88-B460-03B083D56972Q33840400-702D5693-979A-4A06-976B-5CB35A744DD0Q33919178-49F16208-9FB1-4CA6-84EA-282E2D472A3CQ33959808-3FEDD90E-CB7B-420F-A65A-7F8B7967B63BQ34003474-2E97377C-50FD-4F32-8914-BE1F75CAD35AQ34178980-BBA86033-B455-4D13-ABFC-AC507787E3DBQ34346557-7A53876C-DF67-4B37-92F2-65C6AF97525CQ34449234-5CBC35F3-E92E-4073-B466-B40CC9FC76E0Q34626482-54F07652-04EF-4F36-94EC-B66D34AF2E25Q34986856-BD230604-4100-4391-B987-B1C41582FAF1Q35023105-47CFAB3C-A45F-4BD4-ADE8-CFBED318579AQ35240241-F31B9BE0-E016-4BA0-88B9-E10877C4215DQ35368699-4519A575-B387-4168-BDF4-89885503CE85Q35566697-9AF55FD0-2F6B-4337-BDDE-2F902CBCD1E0Q35567088-C8115E86-087A-4605-BF0E-B16F3DEBB5DBQ35608280-80D1E758-C929-44F2-B88B-8969DE4BE2AAQ35671241-FBFE9B3D-EE96-4580-A092-FAA2C17B152AQ35711431-D0D51099-E9C8-47FA-8EDD-9DBF60C55619Q35724847-4AA9D1B8-6A23-4497-9CEF-D5E1EAE3C6D6Q35746347-44C29ADE-2670-401D-A84B-A33E9938D51AQ35972795-52640830-DFC6-4AC5-8B6E-DA5FB463B25BQ36017235-79DC924E-B4F8-4131-818E-E75CB1FFCD0DQ36092271-452817FA-AFB8-4234-A279-8EAF4CA4E72AQ36143295-16F5D84F-2F54-471F-952C-E41FED9D56CC
P2860
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
@ast
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
@en
Guidelines on oral anticoagulation
@nl
type
label
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
@ast
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
@en
Guidelines on oral anticoagulation
@nl
prefLabel
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
@ast
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
@en
Guidelines on oral anticoagulation
@nl
P2093
P2860
P1476
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
@en
P2093
D M Keeling
H G Watson
T P Baglin
P2860
P304
P356
10.1111/J.1365-2141.2005.05856.X
P407
P577
2006-02-01T00:00:00Z